Cellipont Bioservices
Bernard Djom, MBA has a diverse work experience spanning over several years. Bernard'smost recent role is as a CDMO/CMO professional consultant at Djom Biosciences Consultant LLC since February 2022. Prior to that, they worked at Cellipont Bioservices as the Director of Operations since October 2021. Bernard also held the position of Manufacturing Manager at FUJIFILM Diosynth Biotechnologies from June 2021 to October 2021.
From August 2019 to October 2021, Bernard served as the Cell Therapy Manufacturing Supervisor at MaSTherCell. Before that, they worked at Amgen as a Manufacturing Associate III in Cell Culture from September 2015 to November 2019. Additionally, they were a Manufacturing Team Lead Upstream at Lonza from November 2018 to June 2019.
In 2018, Bernard had a role as a Medical Science Liaison at from SCIENCE to PHARMA (FSTP) starting in May. Prior to this, they worked at Baxter Biosciences as a Manufacturing Associate III, Shift Lead for a brief period in 2014. From 2010 to 2013, they served as the Biomedical Laboratory Supervisor at Uphams Corner Health Center. Bernard'swork experience also includes being an HIV/AIDS Service Coordinator at Uphma's Corner Health Center from 2007 to 2008.
Bernard Djom, MBA has a diverse education history. Bernard earned an Executive Master of Business Administration (MBA) degree from the Quantic School of Business and Technology in 2022, with a focus on Business Administration and Management. Prior to that, they obtained a Bachelor's degree in Biomedical Laboratory and Clinical Sciences from Boston University between 2013 and 2017. In addition, Bernard also holds a Certificate in Medical Science Liaison from From Science To Biopharma (2018) and a Certificate in Clinical Trials Management from the University of Delaware Professional & Continuing Studies (2017). Bernard'seducational background also includes a Bachelor of Science (BS) degree in Biomedical Laboratory and Clinical Sciences from Boston University, received between 2010 and 2017. Bernard has also pursued a Bachelor of Applied Science (BASc) in Biomedical and Clinical Sciences and a Bachelor in Science in Biomedial and Clinical Sciences, both from Boston University.
This person is not in any offices
Cellipont Bioservices
Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies. Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients to expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities. We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont Bioservices has very deep technical experience, including 18,000+ tissue samples and more than 900 primary cell cultures. With decades of experience at advanced therapy service companies large and small, our leadership team is guiding Cellipont’s growth with deep knowledge of what it takes succeed in this space. Cellipont Bioservices facilities and quality systems are GMP-compliant and we hold a California Food & Drug Branch manufacturing license. We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches. OUR NAME: By combining “cell” with the latin root for bridge (pont), the name Cellipont Bioservices reflects several dimensions of what we are all about: we bridge our innovator clients with patients; we bridge technical excellence and personal service; and for our team, we bridge personal passion with professional vocation. As we finalize our corporate rebranding, we look forward to launching a new website in the coming weeks to better share our vision with you.